Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04879225 · ClinicalTrials.gov registry record · NA
Menthol and Mint Experimental Tobacco Marketplace (ETM) Study
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT04879225 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 66 participants.
The verdict
NCT04879225, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge of tobacco regulation is weighing the risks and benefits of potential policies across different populations (i.e., users and non-users). Tension arises between policies intended to prevent adolescent and young adult (AYA) tobacco initiation and those intended to reduce harm among current tobacco users. The availability of menthol e-liquids may be important for encouraging menthol cigarette smokers to switch to e- cigarettes, but mint e-liquids, which are appealing to AYA, may be unnecessary to facilitate switching. Including mint e-liquids in flavor bans but allowing menthol e-liquids to remain on the market as potential substitution products for menthol smokers may be an optimal policy approach. The study team is proposing a lab study and field assessment to determine how including menthol and mint e-liquids in e-liquid flavor bans or sales restrictions affects tobacco product purchasing and use among menthol cigarette smokers. At lab sessions, participants will complete the Experimental Tobacco Marketplace (ETM) task, a behavioral economics task in which they receive account balances to an online store and can buy menthol cigarettes at escalating costs or buy e-liquids, non-menthol cigarettes, or nicotine replacement gum at fixed costs. They will complete the task under four marketplace conditions: (1) only tobacco e-liquids available, (2) menthol and tobacco e-liquids available, (3) menthol, mint, and tobacco e-liquids available, and (4) tobacco, menthol, mint, fruit, dessert. During a field assessment, product choice is validated by assessing use of products purchased during the ETM task. This proposal will inform policy-makers about the impact banning menthol and mi
Interventions
- BEHAVIORAL Tobacco e-liquids
- BEHAVIORAL Menthol and Tobacco e-liquids
- BEHAVIORAL Mint, Menthol and Tobacco e-liquids
- BEHAVIORAL All e-liquid flavors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2022-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04879225
The ClinicalTrials.gov registry entry for NCT04879225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Tobacco e-liquids is the first listed.
NCT04879225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04879225 about?
NCT04879225 is a clinical study titled "Menthol and Mint Experimental Tobacco Marketplace (ETM) Study". Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge...
What is the current status of trial NCT04879225?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-06-21. Estimated completion is 2022-12-29.
What interventions are being tested in trial NCT04879225?
The interventions under investigation include: Tobacco e-liquids (BEHAVIORAL), Menthol and Tobacco e-liquids (BEHAVIORAL), Mint, Menthol and Tobacco e-liquids (BEHAVIORAL), All e-liquid flavors (BEHAVIORAL).
Who is sponsoring clinical trial NCT04879225?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.